Advertisement
Advertisement

OGI

OGI logo

Organigram Global Inc. Common Shares

1.31
USD
Sponsored
-0.05
-3.68%
May 11, 15:59 UTC -4
Closed
exchange

After-Market

1.35

+0.04
+2.98%

OGI Earnings Reports

Positive Surprise Ratio

OGI beat 18 of 38 last estimates.

47%

Next Report

Today
Date of Next Report
May 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$71.32M
/
-$0.01
Implied change from Q1 26 (Revenue/ EPS)
+12.25%
/
-107.14%
Implied change from Q2 25 (Revenue/ EPS)
+8.73%
/
-103.03%

Organigram Global Inc. Common Shares earnings per share and revenue

On Feb 10, 2026, OGI reported earnings of 0.14 USD per share (EPS) for Q1 26, beating the estimate of -0.01 USD, resulting in a 1486.14% surprise. Revenue reached 63.54 million, compared to an expected 73.88 million, with a -14.00% difference. The market reacted with a -12.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 71.32 million USD, implying an decrease of -107.14% EPS, and increase of 12.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
logo
CeriBell, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.39
Actual
-$0.52
Surprise
-30.72%
logo
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
logo
Accendra Health, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.04
Surprise
+60.90%
logo
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
logo
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
logo
Exagen Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.17
Surprise
+27.87%
logo
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
logo
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
logo
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
FAQ
For Q1 2026, Organigram Global Inc. Common Shares reported EPS of $0.14, beating estimates by 1486.14%, and revenue of $63.54M, -14% below expectations.
The stock price moved down -12.58%, changed from $1.59 before the earnings release to $1.39 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 3 analysts, Organigram Global Inc. Common Shares is expected to report EPS of -$0.01 and revenue of $71.32M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement